{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:04:58Z","timestamp":1792112698184,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 17K08483"],"award-info":[{"award-number":["JP 17K08483"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.heliyon.2023.e18721","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T10:21:53Z","timestamp":1690453313000},"page":"e18721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Incidence trends and risk factors for hyponatremia in epilepsy patients: A large-scale real-world data study"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8452-448X","authenticated-orcid":false,"given":"Yoshiaki","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9736-7460","authenticated-orcid":false,"given":"Naotaka","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukitoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e18721_bib1","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-13-1020","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"170","author":"Spasovski","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.heliyon.2023.e18721_bib2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1530\/EJE-16-0500","article-title":"Long-term outcome of profound hyponatremia: a prospective 12 months follow-up study","volume":"175","author":"Winzeler","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.heliyon.2023.e18721_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1528-1167.2010.02939.x","article-title":"Hyponatremia and risk of seizures: a retrospective cross-sectional study","volume":"52","author":"Halawa","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.heliyon.2023.e18721_bib4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1528-1157.1984.tb04205.x","article-title":"Carbamazepine and serum sodium levels","volume":"25","author":"Kalff","year":"1984","journal-title":"Epilepsia"},{"key":"10.1016\/j.heliyon.2023.e18721_bib5","first-page":"97","article-title":"Oxcarbazepine and adverse events: impact of age, dosage, metabolite serum concentrations and concomitant antiepileptic therapy","volume":"23","author":"Ortenzi","year":"2008","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.heliyon.2023.e18721_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.seizure.2013.11.015","article-title":"Frequency of and risk factors for oxcarbazepine-induced severe and symptomatic hyponatremia","volume":"23","author":"Kim","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.heliyon.2023.e18721_bib7","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/01.wnl.0000188819.45330.90","article-title":"Hyponatremia from oxcarbazepine and carbamazepine","volume":"65","author":"Dong","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2023.e18721_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/14740338.2017.1248399","article-title":"Hyponatremia induced by antiepileptic drugs in patients with epilepsy","volume":"16","author":"Lu","year":"2017","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.heliyon.2023.e18721_bib9","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/clpt.1985.115","article-title":"Hyponatremia during carbamazepine therapy","volume":"37","author":"Lahr","year":"1985","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2023.e18721_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.797039","article-title":"The role of vasopressin V2 receptor in drug-induced hyponatremia","volume":"12","author":"Kim","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.heliyon.2023.e18721_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eplepsyres.2018.03.023","article-title":"Antiepileptic drugs-induced hyponatremia: review and analysis of 560 hospitalized patients","volume":"143","author":"Intravooth","year":"2018","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.heliyon.2023.e18721_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.seizure.2018.04.025","article-title":"Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: a population-based case-control study","volume":"59","author":"Falhammar","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.heliyon.2023.e18721_bib13","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1345\/aph.1G209","article-title":"Carbamazepine-induced hyponatremia: assessment of risk factors","volume":"39","author":"Kuz","year":"2005","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.heliyon.2023.e18721_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1365-2788.2001.00338.x","article-title":"Hyponatremia during carbamazepine therapy in patients with intellectual disability","volume":"45","author":"Kelly","year":"2001","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.heliyon.2023.e18721_bib15","doi-asserted-by":"crossref","first-page":"F963","DOI":"10.1152\/ajprenal.00576.2020","article-title":"Psychotropic drugs upregulate aquaporin-2 via vasopressin-2 receptor\/cAMP\/protein kinase A signaling in inner medullary collecting duct cells","volume":"320","author":"Kim","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.heliyon.2023.e18721_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ana.410430219","article-title":"Hyponatremia due to sodium valproate","volume":"43","author":"Branten","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.heliyon.2023.e18721_bib17","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0140-6736(00)02613-1","article-title":"Hyponatraemia associated with lamotrigine in cranial diabetes insipidus","volume":"356","author":"Mewasingh","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2023.e18721_bib18","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1528-1167.2005.64004.x","article-title":"Hyponatremia associated with repeated use of levetiracetam","volume":"46","author":"Nasrallah","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.heliyon.2023.e18721_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.seizure.2019.10.013","article-title":"Prevalence and risk factors for hyponatremia in adult epilepsy patients: large-scale cross-sectional cohort study","volume":"73","author":"Yamamoto","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.heliyon.2023.e18721_bib20","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: the DDD method","volume":"42","author":"Leucht","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.heliyon.2023.e18721_bib21","doi-asserted-by":"crossref","first-page":"e729","DOI":"10.1097\/MJT.0000000000000745","article-title":"Lacosamide: associated hyponatremia","volume":"25","author":"Gupta","year":"2018","journal-title":"Am. J. Therapeut."},{"key":"10.1016\/j.heliyon.2023.e18721_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3988\/jcn.2021.17.3.393","article-title":"Epidemiology committee of Korean epilepsy society. Increasing trends in the incidence and prevalence of epilepsy in korea","volume":"17","author":"Jeon","year":"2021","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.heliyon.2023.e18721_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178977","article-title":"Hyponatremia and increased risk of dementia: a population-based retrospective cohort study","volume":"12","author":"Chung","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e18721_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/20420188221097343","article-title":"The management of acute and chronic hyponatraemia","volume":"13","author":"Lawless","year":"2022","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.heliyon.2023.e18721_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/epi.17117","article-title":"Antiseizure medications and thyroid hormone homeostasis: literature review and practical recommendations","volume":"63","author":"Rochtus","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.heliyon.2023.e18721_bib26","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1530\/EJE-16-0493","article-title":"Management of endocrine disease: hypothyroidism-associated hyponatremia: mechanisms, implications and treatment","volume":"176","author":"Liamis","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.heliyon.2023.e18721_bib27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.amjmed.2012.06.037","article-title":"Electrolyte disorders in community subjects: prevalence and risk factors","volume":"126","author":"Liamis","year":"2013","journal-title":"Am. J. Med."},{"key":"10.1016\/j.heliyon.2023.e18721_bib28","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/bmj.297.6652.858-b","article-title":"Inappropriate secretion of antidiuretic hormone associated with lorazepam","volume":"297","author":"Engel","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2023.e18721_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2021.110654","article-title":"Management of SIADH-related hyponatremia due to psychotropic medications - an expert consensus from the Association of Medicine and Psychiatry","volume":"151","author":"Pinkhasov","year":"2021","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.heliyon.2023.e18721_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejim.2018.11.011","article-title":"Antipsychotics and severe hyponatremia: a Swedish population-based case-control study","volume":"60","author":"Falhammar","year":"2019","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.heliyon.2023.e18721_bib31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5937\/jomb0-30409","article-title":"Hyponatremia: is it related to the seasons?","volume":"40","author":"Altuntas","year":"2021","journal-title":"J. Med. Biochem."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023059297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023059297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:29:37Z","timestamp":1783114177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023059297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2405844023059297"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18721","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence trends and risk factors for hyponatremia in epilepsy patients: A large-scale real-world data study","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e18721"}}